Equity Incentive Plan (Tables)

12 Months Ended

Dec. 31, 2021

Share-Based Payment Arrangement [Abstract]

Schedule of share-based compensation expense

	Year ended December 31,
(in thousands)	2021		2020
General and administrative	$	933	$	444
Sales and marketing		116		127
Research and development		242		66
Cost of revenues		96		31
	$	1,387	$	668

Schedule of fair value of option grants weighted average assumptions

	December 31,
	2021			2020
Expected term (in years)		5.7			5.7
Expected Volatility		54.3	%		42.9	%
Risk-free rate		0.8	%		0.5	%
Dividend rate		—			—

Schedule of stock option activity

	Number of Shares under Option Plan			Weighted- Average Exercise Price per Option		Weighted- Average Remaining Contractual Life (in years)
Outstanding at December 31, 2020		4,211,857		$	0.76		8.6
Granted		2,768,972			3.26
Exercised		(254,496	)	$	0.81
Forfeited and expired		(142,952	)	$	2.26
Outstanding at December 31, 2021		6,583,381		$	1.78		8.0
Exercisable at December 31, 2021		3,692,110		$	1.11		7.8
Vested and expected to vest at December 31, 2021		6,583,381		$	1.78		8.0